Analyst Ratings for Sana Biotechnology (SANA)
SANA Rating Summary
SANA Price Target Summary
- Highest: $15.00 (JMP Securities)
- Lowest: $8.00 (Citi)
- Average: $11.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.67 (+30.9%)
* Over Last 12-Mos
Rating Score: 6.3 / 10 Percentile Rank: 67%
Rating Score: 6.3 / 10 Percentile Rank: 67%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/16/2024 | H.C. Wainwright | Emily Bodnar | Upgrade | Buy (Neutral) |
12.00 (N/A) |
6.32 (8.91) |
40.98% | Details |
9/25/2023 | JMP Securities » Updated 3/1/2024 |
Reni Benjamin | New Coverage | Market Outperform (N/A) |
15.00 (8.00) |
3.96 (8.91) |
125% | Details |
SANA Ratings News
- H.C. Wainwright Upgrades Sana Biotechnology (SANA) to Buy
- JMP Securities Starts Sana Biotechnology (SANA) at Market Outperform, 'Taking Engineering Where No Cell Has Gone Before'
- Citi Starts Sana Biotechnology (SANA) at Buy, 'Hypoimmune Platform is a Potential Game Changer for Allogeneic Cell Therapy'
- See More